semaglutide weight loss long term Semaglutide results week by week:

The Once-Weekly Semaglutide in Adults with Overweight or Obesity STEP 1 trial (Wilding et al., NEJM, 2021) found that adults taking the 2.4 mg weekly dose lost a mean of 14.9% of body weight over 68 weeks, versus 2.4% on placebo, and 86.4% achieved at least 5% weight loss

Intramuscular Injection Works Differently Subcutaneous injections place medication in the fatty layer between skin and muscle, where blood vessels and absorption rates are optimized for steady, predictable medication delivery

The starting dose is typically low and increases every few weeks until the target dose is reached

Obesity rates are also associated with income

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Yaribeygi H., Farrokhi F.R., Abdalla M.A., et al